Methylene tetrahydrofolate reductase C677T polymorphism in Korean livedoid vasculopathy patients - 10/03/21
Doi : 10.1016/j.jaad.2020.05.158
Ji Su Lee, MD a, Soyun Cho, MD, PhD a, b, ⁎ 
a Department of Dermatology, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Korea
b Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea
∗Correspondence to: Soyun Cho, MD, PhD, Department of Dermatology, Seoul Metropolitan Government—Seoul National University (SMG-SNU) Boramae Medical Center, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, KoreaDepartment of DermatologySeoul Metropolitan Government—Seoul National University (SMG-SNU) Boramae Medical Center20, Boramae-ro 5-gil, Dongjak-guSeoul07061Korea
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the Seoul National University Boramae Medical Center Institutional Review Board (No. 20-2018-64/082). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 4
P. 1068-1069 - avril 2021 Retour au numéro
Article précédent
- Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent
- Robert Bissonnette, Linda Stein Gold, David S. Rubenstein, Anna M. Tallman, April Armstrong
- Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms
- Erik A. Williams, Nikunj Shah, Natalie Danziger, Meagan Montesion, Ethan S. Sokol, Dean C. Pavlick, Vincent A. Miller, Jeffrey S. Ross, Julia A. Elvin, Julie Y. Tse
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?